Non-cytotoxic therapies for malignant gliomas.
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 58 (1) , 57-69
- https://doi.org/10.1023/a:1015839111005
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Tyrosine kinase inhibitors—ZD1839 (Iressa)Current Opinion in Oncology, 2001
- A phase III study of radiation therapy plus carmustine with or without recombinant interferon-? in the treatment of patients with newly diagnosed high-grade gliomaCancer, 2001
- Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.2001
- Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.2000
- Targeted Toxin Therapy for Malignant AstrocytomaNeurosurgery, 2000
- Retinoic acid modulates RAR alpha and RAR beta receptors in human glioma cell lines.2000
- Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain TumorsCancer Control, 1998
- Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations.Journal of Clinical Oncology, 1997
- Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetateJournal of Neurosurgery, 1995
- Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI.1994